Articles

Find an Article

Filter articles

Showing 81 to 90 of 635 results

Searching for variant sequences with pinpoint accuracy

12-07-2018Ellen Sherin 

The world of sequence variation IP is complicated and confusing, and fraught with legal risk, but there is a solution, as Ellen Sherin of GQ Life Sciences reports.

LSIPR 50 2018: Leading the transformation change

US12-07-2018

Scott Alban of AstraZeneca outlines the company’s recent transformation aimed at breaking down barriers and the uncharted territories that it is eager to explore.

LSIPR 50 2018: The promise of IP

US11-07-2018

Since joining Eli Lilly’s patent division nearly 20 years ago, Manisha Desai has worked on the procurement and enforcement of patents worldwide.

Plant patents in Mexico: uncertainty ahead

Mexico10-07-2018Daniel Eduardo López and Esteban Rodríguez

A shift in Mexico’s examination practice on plant-related patents has caused legal uncertainty, say Daniel Eduardo López and Esteban Rodríguez of Clarke Modet & Co.

LSIPR 50 2018: Helping to shape the healthcare landscape

Nigeria10-07-2018

A lack of blood donors and poor healthcare infrastructure inspired Temie Giwa-Tubosun to develop and deliver a life-saving app. LSIPR spoke to the founder of LifeBank.

LSIPR 50 2018: At the head of an experiment in innovation

France09-07-2018

Marie-Paule Kieny of the Drugs for Neglected Diseases Initiative is on a mission to remind stakeholders and governments that there is a moral imperative to pursue the fight against neglected diseases, as she tells LSIPR.

LSIPR 50 2018: A decade in the making, a Parkinson’s breakthrough

UK06-07-2018

A team at the University of Dundee has announced a major breakthrough in the understanding of Parkinson’s disease. LSIPR heard more from Miratul Muqit and Daan van Aalten of the university’s school of life sciences.

LSIPR 50 2018: Dreaming big to fight HIV

05-07-2018

Glenda Gray, CEO and president of the South African Medical Research Council, tells LSIPR of the life-saving work she is undertaking and her ambitious goals to improve the South African healthcare landscape.

LSIPR 50 2018: It’s not like selling cars

US04-07-2018

Balancing a company’s duty to shareholders with the public responsibility to provide lifesaving treatments is a constant challenge, as Issi Rozen, chief business officer at the Broad Institute of MIT and Harvard, tells LSIPR.

LSIPR 50 2018: Big changes in Brazil

Brazil03-07-2018

With his interests in IP development, biotechnology innovation policy, and R&D, Luiz Otávio Pimentel, president of Brazil’s patent office, tells LSIPR of his aims to improve the country’s IP performance.

Showing 81 to 90 of 635 results

LSIPR